|
Syngenta has compiled an impressive portfolio of proprietary technologies and
related patents. The company seeks to capture additional value from this
portfolio through outlicensing, especially in the area of genomics and
biotechnology. Syngenta views outlicensing as one of the key business outputs
flowing from the companys strategic objectives: (Business
Outputs)
Under its outlicensing program, Syngenta can offer research and/or commercial
licenses to both academic and commercial entities. The following
technologies are currently available for outlicensing. Additional technologies
will be added to the list as they become available in the future. If you would
like to be informed by e-mail when new technologies are available, submit your
request by accessing the link below.
Links to technologies available for outlicensing:
Additional technologies will be added to the list as they become available in
the future. If you would like to be informed by e-mail when new technologies
are available, submit your request by accessing the link below.
How to contact us:
Global Biotechnology Licensing
Syngenta Biotechnology, Inc.
3054 Cornwallis Road
Research Triangle Park, NC USA 27709-2257
Phone: 919-597-3031
For inquiries about licenses for academic or not-for-profit organizations,
contact
For inquiries about licenses for commercial organizations, contact
|
